Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Disease Among Three Lexicon-Sponsored Presentations at the 2024 Annual Conference of the Association of Diabetes Care & Education Specialists

August 8, 2024

https://www.globenewswire.com/news-release/2024/08/07/2925879/0/en/Efficacy-and-Safety-Data-of-Sotagliflozin-in-Patients-with-Type-1-Diabetes-and-Chronic-Kidney-Disease-Among-Three-Lexicon-Sponsored-Presentations-at-the-2024-Annual-Conference-of-t.html

THE WOODLANDS, Texas, Aug. 07, 2024 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX) today announced that three poster presentations will be delivered during the 2024 Annual Conference of the Association of Diabetes Care & Education Specialists being held August 9 – 12, 2024 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.